Facebook
Twitter
LinkedIn
ForwardFrom Hype to Happen: how to evaluate artificial intelligence and automation for your organization
February 29, 2024
This presentation will highlight the impact of artificial intelligence on pharmacy automation (hardware and software) and the downstream impacts on practices within the health system. This topic is important for understanding the efficiency and accuracy of the current and future solutions that are on the market today to support decision making for leaders, pharmacy team members, and other stakeholders. There are also other applications for clinical decision supports, data driven decision-making and analytics, drug information, cost reductions and efficiencies, etc. It is vital to stay up to date with the latest developments in this field and this program will contribute to the continuous learning and understanding of the quickly changing practices within healthcare.
Target Audience
- Pharmacists
- Pharmacy Technicians
Learning Objectives
Pharmacists
At the conclusion of this activity, participants should be able to:
- Define artificial intelligence, automation and related terms.
- Describe approaches to evaluating artificial intelligence and pharmacy automation platforms and software.
- Compare and contrast risks and benefits of incorporating artificial intelligence and pharmacy automation in a health system environment.
- Describe potential applications of AI and pharmacy automation software platforms in Pharmacy
Pharmacy Technicians
- Define artificial intelligence, automation and related terms.
- Compare and contrast risks and benefits of incorporating artificial intelligence and pharmacy automation in a health system environment.
Faculty
Bonnie Levin, PharmD, MBA, FASHP
VP, Pharmacy Services
MedStar Health
Anthony Scott, PharmD, MBA
Director of Pharmacy Services
Emory University Hospital
Planning committee
Gretchen Brummel
Pharmacy Executive Director
Vizient, Inc.
Jackie Stokes
Pharmacy Program Services Manager
Vizient, Inc.
Disclosure
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
FDA Off-Label Use
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
Disclosure Statements
Absence of Relevant Financial Relationships
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Relevant Financial Relationships
Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
[Insert name], speaker for this educational activity, is [nature of relationship(s)] for [insert name of the ineligible company(ies)].
[Insert name], speaker for this educational activity, is [nature of relationship(s)] for [insert name of the ineligible company(ies)].
All relevant financial relationships listed for these individual(s) have been mitigated.
Disclaimer
The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation Statement(s)
Pharmacists (CPE)
Vizient, Inc. designates this live activity for a maximum of 1.00 contact hours for Pharmacists.
Universal Activity Number: JA0006103-0000-24-014-L99-P
Pharmacy Technicians (CPE)
Vizient, Inc. designates this live activity for a maximum of 1.00 contact hours for pharmacy technicians.
Universal Activity Number: JA0006103-0000-24-014-L99-T
Other Healthcare Professionals (General CE Credit)
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician
- 1.00 General CE - Attendance